HUMAN GENOME SCIENCES INC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
HUMAN GENOME SCIENCES INC reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 66.20% for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2012-02-28
- HUMAN GENOME SCIENCES INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2011 was 66.20%, a 1.22% increase from fiscal 2010.
- HUMAN GENOME SCIENCES INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2010 was 65.40%, a 21.68% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2009 was 83.50%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month |
|---|---|
| 2011-12-31 | 66.20% 10-K · filed 2012-02-28 |
| 2010-12-31 | 65.40% 10-K · filed 2012-02-28 |
| 2009-12-31 | 83.50% 10-K · filed 2012-02-28 |